Trial Title: A Study of the Safety and Scientific Action of Stanate in Infants at Risk for Exchange Transfusion

Trial Therapeutic Area: Hematology

Trial Country Location(s): Global

Trial Patient Population:
Ages Eligible for Study:  up to  7 Days,  Genders Eligible for Study:  Both

Investigator Requirments:

Trial Inclusion/Exclusion Criteria:
Inclusion Criteria:

• Term and near-term healthy infants (may be no more than 14 days of age) with excessive hyperbilirubinemia who are at risk for exchange transfusion according to the AAP guidelines of 2004

Exclusion Criteria:

• No parental consent
• Major known congenital anomaly
• Current use of antibiotics, cardio-respiratory instability, abnormal renal function, hepatitis (as related to TORCH infections)
• Phenobarbital use in either child or mother (30 days prior to child’s birth)

Other Trial Details:

Addn'tl Person of Contact Info:
Richard McCleod, MD  
Phone: 614-722-2718